21 May 2013
Keywords: review, second, qtr, implications, euro, firms, major
Article | 20 August 1998
As the major US pharmaceutical companies conclude reporting theirresults for the second quarter of 1998, analysts at Goldman Sachs have
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 August 1998
20 May 2013
© 2013 thepharmaletter.com